Microbix Biosystems Inc http://www.alacrastore.com/company-snapshot/Microbix_Biosystems_Inc-2112204 Monday, October 13, 2008 11:03:43 PM 2112204 Microbix Biosystems Inc en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/PRN-0001-28275630newstex/PRN-0001-28275630xml Sep. ##, #### (Canada NewsWire Group delivered by Newstex) -- TORONTO, Sept. ## /CNW/ -- Microbix Biosystems Inc. (TSX:MBX) announced today that it has completed a $#.# million acquisition of all Urokinase assets from ImaRx Therapeutics,...070000000701300004000000040020000400200604016000040160050400700004007005040060000400600204009000040090010200000002002000020020069/24/2008 9:23:37 AM1800000018016000180200001800900019000000190010001900200019002012Canada NewsWire GroupPRN-0001-28275630IMARX THERAPEUTICS INCMICROBIX BIOSYSTEMS INCIMRXMBXNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0001-27372482newstex/PRN-0001-27372482xml Aug. ##, #### (Canada NewsWire Group delivered by Newstex) -- TORONTO, Aug. ## /CNW/ -- Microbix Biosystems Inc. (TSX:MBX) today announced results for the third quarter ended June ##, ####, and outlined steps that have been taken in...0700000007003000070030060400000004016000040160130401602704016018110000001101600011016001020000000200200002002008020020068/13/2008 9:22:07 AM1800000018018000180150001800400018020000Canada NewsWire GroupPRN-0001-27372482MICROBIX BIOSYSTEMS INCMBXNewsNewstexUS - Microbix Biosystems Inc signed a Letter of Intent {LoI} to acquire the urokinase inventory and related assets of ImaRx Therapeutics Inc, a manufacturer, developer and marketer of thrombolytic drugs and therapies, for an estimated $## mil. The consideration was to consist of $## mil in cash and up to $# mil in profit related payments.5/8/2008 4:42:47 PM59501P46567659501P465676Microbix Biosystems IncIthaca Energy IncMicrobix Biosystems IncIthaca Energy Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/Microbix_Biosystems_Inc_acquires_Ithaca_Energy_Inc-1975742020sdc/19757420201975742020Copyright © 2008, Thomson Financial, All Rights ReservedTorontoDrugsCanadaBiological products, except diagnostic substances2836FFForeignPublicMBX2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizations2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizationsTSXVentureOil and Gas; Petroleum RefiningCanadaCrude petroleum and natural gas1311FFForeignPublicIAE245018001Biotech coOil,gas expl,prodnCashEarnoutAssets982135002May 8 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.00000Microbix Biosystems Inc,located in Toronto, Canada, isa biotechnology companyspecializing in thedevelopment of proprietarybiological technologies inthree areas known asBiotherapeutics, vaccines andnon-therapeutic biologics. TheCompany was founded in 1988.Microbix Biosystems Inc, located in Toronto, Canada, is abiotechnology company specializing in the development ofproprietary biological technologies in three areas known asBiotherapeutics, vaccines and non-therapeutic biologics. TheCompany was founded in 1988.Microbix Biosystems Inc, located in Toronto, Canada, is a biotechnology company specializing in the development of proprietary biological technologies in three areas known as Biotherapeutics, vaccines and non-therapeutic biologics. The Company was founded in 1988.1.000002.000003.000004.00000Ithaca Energy, located inCalgary, is an oil and gasexploration and productioncompany.Ithaca Energy, located in Calgary, is an oil and gasexploration and production company.Ithaca Energy, located in Calgary, is an oil and gas exploration and production company.0.000000.000000.000000.00000NU.S. Dollar07 May 08Wed, 07 May 2008 00:00:00 ESTDate Announced: 05/07/2008Date Effective:Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000017 U.S. Dollar17.000000.0000017 U.S. Dollar17.000000.000000.000000.000000.0000017.0000017 U.S. Dollar1.00000N8.616000.000000.000000.000000.000000.0000017.0000017.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.00000US - Microbix Biosystems Incsigned a Letter of Intent{LoI} to acquire the urokinaseinventory and related assetsof ImaRx Therapeutics Inc, amanufacturer, developer andmarketer of thrombolytic drugsand therapies, for anestimated $17 mil. Theconsideration was to consistof $12 mil in cash and up to$5 mil in profit relatedpayments.US - Microbix Biosystems Inc signed a Letter of Intent {LoI} to acquire the urokinase inventory and related assets of ImaRx Therapeutics Inc, a manufacturer, developer and marketer of thrombolytic drugs and therapies, for an estimated $17 mil. The consideration was to consist of $12 mil in cash and up to $5 mil in profit related payments.US - Microbix Biosystems Inc signed a Letter of Intent {LoI} to acquire the urokinaseinventory and related assets of ImaRx Therapeutics Inc, a manufacturer, developer andmarketer of thrombolytic drugs and therapies, for an estimated $17 mil. The considerationwas to consist of $12 mil in cash and up to $5 mil in profit related payments.US - Microbix Biosystems Inc signed a Letter of Intent {LoI} to acquire the urokinase inventory and related assets of ImaRx Therapeutics Inc, a manufacturer, developer and marketer of thrombolyticdrugs and therapies, for an estimated $17 mil. The consideration was to consist of $12 mil in cash and up to $5 mil in profit related payments.US - Microbix Biosystems Inc signed a Letter of Intent {LoI} to acquire the urokinase inventory and related assets of ImaRx TherapeuticsInc, a manufacturer, developer and marketer of thrombolytic drugs and therapies, for an estimated $17 mil. The consideration was toconsist of $12 mil in cash and up to $5 mil in profit related payments.Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001311:Crude petroleum and natural gas1381:Drilling oil and gas wells1382:Oil and gas field exploration services245018001TorontoCanada2836ForeignPublicMBX1311:Crude petroleum and natural gas1381:Drilling oil and gas wells1382:Oil and gas field exploration services982135002TSXVentureCanada1311ForeignPublicIAE17.0000017.0000017.000008.61600Deal InformationTF Mergers & Acquisitions